放射性医薬品の世界市場2020-2024:診断、治療薬

Technavioが発行した調査報告書(IRTNTR43963)
◆英語タイトル:Global Radiopharmaceuticals Market 2020-2024
◆商品コード:IRTNTR43963
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年6月
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥265,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥318,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、放射性医薬品の世界市場について調査・分析を行い、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別(診断、治療薬)分析、顧客状況、地域別状況、企業状況、企業分析などを掲載しております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・放射性医薬品の世界市場規模:用途別(診断、治療薬)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Radiopharmaceuticals Market 2020-2024
Technavio has been monitoring the radiopharmaceuticals market and it is poised to grow by $ 3.58 bn during 2020-2024 progressing at a CAGR of 10% during the forecast period. Our reports on radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising burden of the neurological disorders, growing cancer cases and rising investment in oncology market, and minimal side effects of the radiopharmaceuticals as compared with its potential benefits. In addition, rising burden of the neurological disorders is anticipated to boost the growth of the market as well.
The radiopharmaceuticals market analysis includes application segment and geographic landscapes
Technavio’s radiopharmaceuticals market is segmented as below:
By Application
• Diagnostics
• Therapeutic
By Geographic Landscapes
• North America
• Europe
• APAC
• South America
• MEA
This study identifies the partnerships for development of radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, production based on cyclotron will lead to sizable demand in the market.
“Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our radiopharmaceuticals market covers the following areas:
• Radiopharmaceuticals market sizing
• Radiopharmaceuticals market forecast
• Radiopharmaceuticals market industry analysis”
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, BWX Technologies Inc., Cardinal Health Inc., Curium, Eckert & Ziegler AG, Eli Lilly and Co., General Electric Co., Lantheus Holdings Inc., Novartis AG, and Siemens Healthineers AG. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/report/radiopharmaceuticals-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Diagnostics – Market size and forecast 2019-2024
o Therapeutic – Market size and forecast 2019-2024
o Market opportunity by Application
• Customer landscape
o Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o South America – Market size and forecast 2019-2024
o MEA – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Bayer AG
o BWX Technologies Inc.
o Cardinal Health Inc.
o Curium
o Eckert & Ziegler AG
o Eli Lilly and Co.
o General Electric Co.
o Lantheus Holdings Inc.
o Novartis AG
o Siemens Healthineers AG
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ Million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Application – Market share 2019-2024 (%)
• 22: Comparison by Application
• 23: Diagnostics – Market size and forecast 2019-2024 ($ Million)
• 24: Diagnostics – Year-over-year growth 2019-2024 (%)
• 25: Therapeutic – Market size and forecast 2019-2024 ($ Million)
• 26: Therapeutic – Year-over-year growth 2019-2024 (%)
• 27: Market opportunity by Application
• 28: Customer landscape
• 29: Market share by geography 2019-2024 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2019-2024 ($ Million)
• 32: North America – Year-over-year growth 2019-2024 (%)
• 33: Europe – Market size and forecast 2019-2024 ($ Million)
• 34: Europe – Year-over-year growth 2019-2024 (%)
• 35: APAC – Market size and forecast 2019-2024 ($ Million)
• 36: APAC – Year-over-year growth 2019-2024 (%)
• 37: South America – Market size and forecast 2019-2024 ($ Million)
• 38: South America – Year-over-year growth 2019-2024 (%)
• 39: MEA – Market size and forecast 2019-2024 ($ Million)
• 40: MEA – Year-over-year growth 2019-2024 (%)
• 41: Key leading countries
• 42: Market opportunity by geography ($ Million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Bayer AG – Overview
• 50: Bayer AG – Business segments
• 51: Bayer AG – Key offerings
• 52: Bayer AG – Key customers
• 53: Bayer AG – Segment focus
• 54: BWX Technologies Inc. – Overview
• 55: BWX Technologies Inc. – Business segments
• 56: BWX Technologies Inc. – Key offerings
• 57: BWX Technologies Inc. – Key customers
• 58: BWX Technologies Inc. – Segment focus
• 59: Cardinal Health Inc. – Overview
• 60: Cardinal Health Inc. – Business segments
• 61: Cardinal Health Inc. – Key offerings
• 62: Cardinal Health Inc. – Key customers
• 63: Cardinal Health Inc. – Segment focus
• 64: Curium – Overview
• 65: Curium – Product and service
• 66: Curium – Key offerings
• 67: Curium – Key customers
• 68: Curium – Segment focus
• 69: Eckert & Ziegler AG – Overview
• 70: Eckert & Ziegler AG – Business segments
• 71: Eckert & Ziegler AG – Key offerings
• 72: Eckert & Ziegler AG – Key customers
• 73: Eckert & Ziegler AG – Segment focus
• 74: Eli Lilly and Co. – Overview
• 75: Eli Lilly and Co. – Business segments
• 76: Eli Lilly and Co. – Key offerings
• 77: Eli Lilly and Co. – Key customers
• 78: Eli Lilly and Co. – Segment focus
• 79: General Electric Co. – Overview
• 80: General Electric Co. – Business segments
• 81: General Electric Co. – Key offerings
• 82: General Electric Co. – Key customers
• 83: General Electric Co. – Segment focus
• 84: Lantheus Holdings Inc. – Overview
• 85: Lantheus Holdings Inc. – Business segments
• 86: Lantheus Holdings Inc. – Key offerings
• 87: Lantheus Holdings Inc. – Key customers
• 88: Lantheus Holdings Inc. – Segment focus
• 89: Novartis AG – Overview
• 90: Novartis AG – Business segments
• 91: Novartis AG – Key offerings
• 92: Novartis AG – Key customers
• 93: Novartis AG – Segment focus
• 94: Siemens Healthineers AG – Overview
• 95: Siemens Healthineers AG – Business segments
• 96: Siemens Healthineers AG – Key offerings
• 97: Siemens Healthineers AG – Key customers
• 98: Siemens Healthineers AG – Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations



【掲載企業】

Bayer AG, BWX Technologies Inc., Cardinal Health Inc., Curium, Eckert & Ziegler AG, Eli Lilly and Co., General Electric Co., Lantheus Holdings Inc., Novartis AG, Siemens Healthineers AG

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 放射性医薬品の世界市場2020-2024:診断、治療薬(Global Radiopharmaceuticals Market 2020-2024)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆